Dosing Antifungals in Obesity: a Literature Review
- 6 February 2019
- journal article
- review article
- Published by Springer Nature in Current Fungal Infection Reports
- Vol. 13 (1) , 21-32
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Weight Drives Caspofungin Pharmacokinetic Variability in Overweight and Obese People: Fractal Power Signatures beyond Two-Thirds or Three-FourthsAntimicrobial Agents and Chemotherapy, 2013
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting ConcentrationAntimicrobial Agents and Chemotherapy, 2012
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and ToxicityAntimicrobial Agents and Chemotherapy, 2012
- Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell RecipientsAntimicrobial Agents and Chemotherapy, 2012
- Fractal Geometry and the Pharmacometrics of Micafungin in Overweight, Obese, and Extremely Obese PeopleAntimicrobial Agents and Chemotherapy, 2011
- Steady-State Plasma Pharmacokinetics of Oral Voriconazole in Obese AdultsAntimicrobial Agents and Chemotherapy, 2011
- Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or CandidemiaAntimicrobial Agents and Chemotherapy, 2011
- Posaconazole Serum Concentrations among Cardiothoracic Transplant Recipients: Factors Impacting Trough Levels and Correlation with Clinical Response to TherapyAntimicrobial Agents and Chemotherapy, 2011
- Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2009
- Quantification of Lean BodyweightClinical Pharmacokinetics, 2005